Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Menses Phase01:18

Menses Phase

The uterine cycle begins with the menstrual phase, which is considered day one of the cycle and typically lasts about five days. This phase is characterized by the degeneration and shedding of the stratum functionalis, the functional layer of the endometrium.
When fertilization does not occur, the corpus luteum deteriorates, causing a significant drop in the levels of estrogen and progesterone in the body. This hormonal decrease triggers the release of prostaglandins, which cause the uterine...
Irritable Bowel Syndrome III: Medical and Nursing Management01:30

Irritable Bowel Syndrome III: Medical and Nursing Management

Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
Hormonal Regulation of the Menstrual Cycle01:22

Hormonal Regulation of the Menstrual Cycle

The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
Dysrhythmias VII: Nursing Management of Dysrhythmias01:25

Dysrhythmias VII: Nursing Management of Dysrhythmias

Nursing management of dysrhythmias involves the following:AssessmentSubjective Assessment:The initial step involves gathering patient-reported symptoms such as dizziness, palpitations, and chest discomfort. It is crucial to collect a detailed history, including previous heart conditions, current medication use, and lifestyle factors like caffeine and alcohol consumption.Objective Assessment:This involves observing clinical signs such as jugular venous distention, cool and pale skin, and...
Intrauterine Drug Delivery Systems01:21

Intrauterine Drug Delivery Systems

Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cushing's Syndrome: Rapid Evidence Review.

American family physician·2024
Same author

Biomarker-directed targeted therapy plus durvalumab in advanced non-small-cell lung cancer: a phase 2 umbrella trial.

Nature medicine·2024
Same author

Linear Skin Lesion in a Newborn.

American family physician·2023
Same author

Case Report: Extensive Gangrene: A Rare Presentation of Multisystem Inflammatory Syndrome in Children.

The American journal of tropical medicine and hygiene·2022
Same author

Technical Tips in Managing Large Median Lobes During Robot-assisted Radical Prostatectomy.

European urology open science·2022
Same author

Medium-Term Real-World Outcomes of Minimally Invasive Surgical Therapies for Benign Prostatic Hyperplasia: Water Vapor Thermal Therapy (Rezum) <i>vs</i> Prostatic Urethral Lift (UroLift) in a High-Volume Urban Academic Center.

Journal of endourology·2022

Related Experiment Videos

How best to manage dysfunctional uterine bleeding.

David L Maness1, Avinash Reddy, Carolyn L Harraway-Smith

  • 1Department of Family Medicine, University of Tennessee Health Science Center, Memphis, TN, USA. dmaness@uthsc.edu

The Journal of Family Practice
|August 18, 2010
PubMed
Summary
This summary is machine-generated.

Heavy or irregular periods are common and often benign. Management includes conservative treatments for mild cases and specific interventions for moderate dysfunctional uterine bleeding (DUB).

Related Experiment Videos

Area of Science:

  • Gynecology
  • Reproductive Health

Background:

  • Irregular or heavy menstrual bleeding is a frequent gynecological complaint.
  • Most cases are benign and amenable to conservative management.

Purpose of the Study:

  • To outline diagnostic and treatment strategies for dysfunctional uterine bleeding (DUB).
  • To differentiate management approaches based on bleeding severity.

Main Methods:

  • For postmenopausal women, cancer is assessed using endometrial biopsy, transvaginal ultrasound, or saline infusion sonohysterogram.
  • Mild DUB is treated with nonsteroidal anti-inflammatory drugs, levonorgestrel intrauterine devices (IUDs), or danazol.
  • Moderate DUB is managed with oral contraceptive pills, levonorgestrel IUDs, danazol, or tranexamic acid.

Main Results:

  • Conservative management is effective for most cases of abnormal uterine bleeding.
  • Specific diagnostic tools are recommended for postmenopausal women to rule out malignancy.
  • Pharmacological and device-based treatments vary for mild versus moderate DUB.

Conclusions:

  • Dysfunctional uterine bleeding requires a tailored approach based on severity and menopausal status.
  • Early diagnosis and appropriate treatment can effectively manage abnormal uterine bleeding.
  • Conservative and medical treatments are primary options for DUB management.